12.16
price up icon0.16%   0.02
after-market Handel nachbörslich: 12.14 -0.02 -0.16%
loading
Schlusskurs vom Vortag:
$12.14
Offen:
$12.15
24-Stunden-Volumen:
1.35M
Relative Volume:
0.83
Marktkapitalisierung:
$778.98M
Einnahmen:
$139.91M
Nettoeinkommen (Verlust:
$-140.75M
KGV:
-270.82
EPS:
-0.0449
Netto-Cashflow:
$-20.85M
1W Leistung:
-0.73%
1M Leistung:
+19.80%
6M Leistung:
+33.33%
1J Leistung:
+119.10%
1-Tages-Spanne:
Value
$12.14
$12.19
1-Wochen-Bereich:
Value
$11.67
$12.30
52-Wochen-Spanne:
Value
$4.0705
$12.48

Avid Bioservices Inc Stock (CDMO) Company Profile

Name
Firmenname
Avid Bioservices Inc
Name
Telefon
714.508.6100
Name
Adresse
14191 MYFORD ROAD, TUSTIN, CA
Name
Mitarbeiter
371
Name
Twitter
Name
Nächster Verdiensttermin
2024-09-09
Name
Neueste SEC-Einreichungen
Name
CDMO's Discussions on Twitter

Vergleichen Sie CDMO mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
CDMO 12.16 778.98M 139.91M -140.75M -20.85M -0.0449
VRTX 467.01 119.87B 10.63B -479.80M -1.35B 13.33
REGN 762.00 83.27B 13.85B 4.65B 3.32B 35.06
ARGX 567.90 33.96B 1.86B -40.29M -1.28B -4.16
ALNY 232.27 30.18B 2.09B -332.26M 16.06M -4.14
BNTX 101.87 24.42B 3.30B -501.07M 1.03B 11.54

Avid Bioservices Inc Stock (CDMO) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-09-28 Eingeleitet William Blair Mkt Perform
2023-03-14 Hochstufung KeyBanc Capital Markets Sector Weight → Overweight
2021-12-08 Herabstufung KeyBanc Capital Markets Overweight → Sector Weight
2021-03-17 Eingeleitet RBC Capital Mkts Outperform
2020-11-10 Eingeleitet KeyBanc Capital Markets Overweight
2019-12-10 Hochstufung First Analysis Sec Outperform → Strong Buy
2019-10-17 Eingeleitet Stephens Overweight
2019-10-16 Eingeleitet Craig Hallum Buy
2019-06-28 Hochstufung Janney Neutral → Buy
2019-05-09 Herabstufung Janney Buy → Neutral
Alle ansehen

Avid Bioservices Inc Aktie (CDMO) Neueste Nachrichten

pulisher
04:53 AM

Avid Bioservices, Inc. (NASDAQ:CDMO) Shares Acquired by Royce & Associates LP - MarketBeat

04:53 AM
pulisher
Nov 17, 2024

Avid Bioservices, Inc. (CDMO): A Bull Case Theory - Insider Monkey

Nov 17, 2024
pulisher
Nov 17, 2024

Janney Montgomery Scott LLC Buys 1,800 Shares of Avid Bioservices, Inc. (NASDAQ:CDMO) - Defense World

Nov 17, 2024
pulisher
Nov 15, 2024

Avid Bioservices gains as holder opposes $12.50 a share takeover - MSN

Nov 15, 2024
pulisher
Nov 14, 2024

Punch and Associates Sends Letter to Board of Directors of Avid Bioservices, Inc - Marketscreener.com

Nov 14, 2024
pulisher
Nov 14, 2024

Punch and Associates sends letter to Board of Directors of Avid Bioservices, Inc. - Voice Of Alexandria

Nov 14, 2024
pulisher
Nov 13, 2024

Significant Shareholder Brock Pond Capital Partners Sends Letter to Avid Bioservices Company Board of Directors Opposing GHO/Ampersand Transaction - Longview News-Journal

Nov 13, 2024
pulisher
Nov 13, 2024

Avid Bioservices, Inc. (NASDAQ:CDMO) Shares Bought by GSA Capital Partners LLP - MarketBeat

Nov 13, 2024
pulisher
Nov 12, 2024

Avid Bioservices' SWOT analysis: biomanufacturing stock faces acquisition, growth challenges - Investing.com Australia

Nov 12, 2024
pulisher
Nov 11, 2024

GHO, Ampersand to take Avid Bioservices private - BioCentury

Nov 11, 2024
pulisher
Nov 11, 2024

GHO Capital Partners and Ampersand Capital Partners’ $1.1 Billion Acquisition of Avid Bioservices - Global Legal Chronicle

Nov 11, 2024
pulisher
Nov 11, 2024

Avid Bioservices to be acquired for $1.1B in cash by GHO, Ampersand - MSN

Nov 11, 2024
pulisher
Nov 11, 2024

Creative Planning Raises Stock Holdings in Avid Bioservices, Inc. (NASDAQ:CDMO) - Defense World

Nov 11, 2024
pulisher
Nov 09, 2024

AVID BIOSERVICES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avid Bioservices, Inc.CDMO - Business Wire

Nov 09, 2024
pulisher
Nov 09, 2024

Avid Bioservices (NASDAQ:CDMO) Sees Strong Trading VolumeTime to Buy? - MarketBeat

Nov 09, 2024
pulisher
Nov 09, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CDMO, VINE, YOTA on Behalf of Shareholders - GlobeNewswire Inc.

Nov 09, 2024
pulisher
Nov 09, 2024

Avid Bioservices to be taken private by GHO, Ampersand in $1.1 billion deal - MSN

Nov 09, 2024
pulisher
Nov 09, 2024

Avid Bioservices Enters Agreement to Merge with Space Finco, Inc., Parent, and Merger Sub - Defense World

Nov 09, 2024
pulisher
Nov 09, 2024

Avid Bioservices: Take-Private Deal At A Reasonable Price, Maintaining Buy (NASDAQ:CDMO) - Seeking Alpha

Nov 09, 2024
pulisher
Nov 08, 2024

Private Equity Is Picking Up Biologics CDMO Avid Bioservices in $1.1B Acquisition - MSN

Nov 08, 2024
pulisher
Nov 08, 2024

Avid Bioservices to be Acquired in $1.1 Billion Deal - Yahoo Finance

Nov 08, 2024
pulisher
Nov 08, 2024

Ademi LLP Investigates Whether Avid Bioservices, Inc. Is Obtaining a Fair Price for Its Public Shareholders - Business Wire

Nov 08, 2024
pulisher
Nov 08, 2024

Shareholder Alert: Ademi LLP Investigates Whether Avid Bioservices, Inc. Is Obtaining a Fair Price for Its Public Shareholders - Business Wire

Nov 08, 2024
pulisher
Nov 07, 2024

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Avid Bioservices, Inc. - cnhinews.com

Nov 07, 2024
pulisher
Nov 07, 2024

CDMO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Avid Bioservices, Inc. Is Fair to Shareholders - Business Wire

Nov 07, 2024
pulisher
Nov 07, 2024

Avid Bioservices (NASDAQ:CDMO) Shares Gap UpStill a Buy? - MarketBeat

Nov 07, 2024
pulisher
Nov 07, 2024

Rx Rundown: Avid Bioservices, Novo Nordisk, Zealand Pharma and more - MM+M Online

Nov 07, 2024
pulisher
Nov 07, 2024

GHO, Ampersand take Avid Bioservices private for $1.1B - Axios

Nov 07, 2024
pulisher
Nov 07, 2024

CDMO Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Avid Bioservices to GHO Capital Partners and Ampersand Capital Partners - ForexTV.com

Nov 07, 2024
pulisher
Nov 07, 2024

Avid Bioservices Shares Rise After $1.1B Buyout Offer - MarketWatch

Nov 07, 2024
pulisher
Nov 07, 2024

Avid Bioservices To Be Acquired By GHO And Ampersand - Contract Pharma

Nov 07, 2024
pulisher
Nov 07, 2024

PR News | JF, ICR Healthcare Work Avid's Go-Private DealThu., Nov. 7, 2024 - O'Dwyer's PR News

Nov 07, 2024
pulisher
Nov 07, 2024

Avid Bioservices to be acquired for $1.1B in cash by GHO, Ampersand (NASDAQ:CDMO) - Seeking Alpha

Nov 07, 2024
pulisher
Nov 07, 2024

Avid Bioservices' (CDMO) Sector Perform Rating Reaffirmed at Royal Bank of Canada - MarketBeat

Nov 07, 2024
pulisher
Nov 07, 2024

William Blair Reaffirms Market Perform Rating for Avid Bioservices (NASDAQ:CDMO) - MarketBeat

Nov 07, 2024
pulisher
Nov 07, 2024

Avid Bioservices to be sold to private equity firms for $1.1B - Endpoints News

Nov 07, 2024
pulisher
Nov 07, 2024

GHO and Ampersand Capital to acquire Avid Bioservices - Yahoo Finance

Nov 07, 2024
pulisher
Nov 07, 2024

PE to buy CDMO Avid Bioservices for $1.1 billion - BioProcess Insider

Nov 07, 2024
pulisher
Nov 07, 2024

The five-year returns have been strong for Avid Bioservices (NASDAQ:CDMO) shareholders despite underlying losses increasing - Simply Wall St

Nov 07, 2024
pulisher
Nov 07, 2024

$1.1B acquisition prompts RBC to downgrade avid bioservices stock By Investing.com - Investing.com UK

Nov 07, 2024
pulisher
Nov 07, 2024

Avid Bioservices to go private in $1.1bn private equity deal - pharmaphorum

Nov 07, 2024
pulisher
Nov 07, 2024

Hershey, Upwork And 3 Stocks To Watch Heading Into Thursday - Benzinga

Nov 07, 2024
pulisher
Nov 06, 2024

Avid Bioservices to Go Private in $1.1 Billion Deal - MSN

Nov 06, 2024
pulisher
Nov 06, 2024

Avid Bioservices to be taken private by GHO, Ampersand in $1.1 bln deal - Reuters

Nov 06, 2024
pulisher
Nov 06, 2024

Avid Bioservices to be Acquired by GHO Capital Partners and Ampersand Capital Partners in $1.1 Billion Transaction - GlobeNewswire

Nov 06, 2024
pulisher
Nov 06, 2024

(CDMO) Technical Data - Stock Traders Daily

Nov 06, 2024
pulisher
Nov 03, 2024

1,448,916 Shares in Avid Bioservices, Inc. (NASDAQ:CDMO) Bought by Emerald Advisers LLC - MarketBeat

Nov 03, 2024
pulisher
Nov 02, 2024

Avid Bioservices, Inc. (NASDAQ:CDMO) Receives $13.50 Average Target Price from Analysts - Defense World

Nov 02, 2024
pulisher
Oct 30, 2024

Brokerages Set Avid Bioservices, Inc. (NASDAQ:CDMO) Price Target at $13.50 - MarketBeat

Oct 30, 2024
pulisher
Oct 29, 2024

Avid Bioservices (NASDAQ:CDMO) Shares Cross Above 200 Day Moving AverageHere's Why - MarketBeat

Oct 29, 2024
pulisher
Oct 28, 2024

Avid Bioservices' Record-breaking Quarterly Revenue Ignites Hope For 2025 - RTTNews

Oct 28, 2024

Finanzdaten der Avid Bioservices Inc-Aktie (CDMO)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$18.98
price up icon 3.66%
$76.97
price up icon 1.45%
$39.51
price up icon 7.22%
$359.21
price down icon 1.11%
$187.69
price down icon 0.81%
$101.87
price up icon 2.16%
Kapitalisierung:     |  Volumen (24h):